|
0
Votes
vote
Galapagos collaborates with Charley's Fund, Nash Avery Foundation to develop SARM candidate drug for Duchenne muscular dystrophyMECHELEN, BELGIUM and GREAT BARRINGTON, MA--(Marketwire - September 17, 2009) - * Second indication for Galapagos candidate drug G100192 * Sponsored by Charley's Fund and Nash Avery Foundation * Initiation of preclinical development Galapagos NV (Euronext: GLPG), Charley's Fund I... |

